SpaceX~$1TSpaceX~$1T
Insider Buying
Subscribe
All stock lists
IRON

Disc Medicine, Inc. (IRON)

United States · Delayed Price · Currency is USD
Pharmaceutical Preparations
77.27+2.75 (+3.70%)
 
Insider Score
––Not scored
IRON Insider Score

Insiders filed in the last 90 days, but none of those trades qualified for scoring — round-trip buys and filings whose price is far off the market are excluded.

IRON Income Statement

Fiscal PeriodQ2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025
Period EndingJun 30, 2026Mar 31, 2026Dec 31, 2025Sep 30, 2025Jun 30, 2025Mar 31, 2025
Revenue0.000.000.000.000.00—
Revenue Growth (YoY)——————
Cost of Revenue——————
Gross Profit——————
SG&A Expense18.14 M23.62 M20.75 M17.36 M15.09 M—
R&D Expense46.93 M45.90 M46.22 M50.33 M46.32 M—
Operating Expenses65.08 M69.52 M66.97 M67.70 M61.41 M—
Operating Income-65.08 M-69.52 M-66.97 M-67.70 M-61.41 M—
Pretax Income-59.46 M-63.45 M-60.44 M-62.22 M-55.20 M—
Tax Provision69.00 K51.00 K88.00 K102.00 K52.00 K—
Net Income-59.53 M-63.50 M-60.53 M-62.32 M-55.25 M—
EPS (Basic)-1.54-1.65—-1.77-1.58-1.02
EPS (Diluted)-1.54-1.65—-1.77-1.58-1.02
Shares Outstanding38.69 M38.49 M—35.18 M35.02 M33.32 M

Quarterly figures; YoY compares the same fiscal quarter a year earlier. Source: public market data.

Disclaimer — Informational only — not investment advice. Insider transaction data is sourced from SEC Form 4 filings; market data from public feeds and may be delayed. The Insider Score is a proprietary score for research purposes and does not predict future performance. Always do your own research.